Skip to main content

Effectiveness and Durability of Bivalent COVID-19 mRNA Vaccines

Annex: Statement on the antigen composition of COVID-19 vaccines

COVID-19 vaccines may undergo major overhaul this fall

Why most Canadians don’t need another COVID-19 booster – at least not yet

Studies show real-world usefulness of bivalent COVID boosters

Durability of bivalent boosters against Omicron subvariants

Bivalent Covid boosters ‘moderately durable’

Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19

Who Should Get a Covid Booster Now? New Data Offers Some Clarity.

What’s next for COVID-19 vaccines? Scientists and regulators chart a course amid uncertainty

Gillings study shows updated bivalent boosters are more effective at preventing hospitalization and death from omicron

Two new studies paint encouraging picture of Covid-19 vaccine’s performance

Covid Vaccines Targeting Omicron Should Be Standard, Panel Says

Updated Booster Shots, Not Original COVID Vaccines, Should Be Standard: FDA Panel

Study shows COVID-19 vaccines offer lasting protection

COVID-19: mRNA vaccines provide durable protection against severe illness

Study: Effectiveness of COVID-19 Vaccines Over 9 Months in NC

We don’t need universal booster shots. We need to reach the unvaccinated.

Vaccines provide ongoing prevention of hospitalisation and death – Large US study

COVID19 vaccines offer lasting protection, claims study

Study finds Moderna COVID vaccine efficacy peaks at 94% after 120 days

Durability of mRNA-1273 Protection Against Symptomatic COVID-19 Examined

Lin’s New England Journal of Medicine article makes case for children’s COVID-19 boosters

Study finds Pfizer vaccine boosts, not destroys, immunity from past COVID-19 infection

Fact Check-Vaccine-effectiveness study does not show ‘negative immunity’ or harm to the immune system

NCDHHS announces availability of updated COVID-19 boosters, aims to combat new subvariants

JAMA study shows COVID-19 vaccines, boosters and prior infection provide durable protection against severe outcomes of SARS-CoV-2 infection

COVID-19 vaccines protect against severe outcomes but less so over time

Primary vaccinations and boosters effective in reducing COVID-19 severity during Delta and Omicron predominance

Huge Studies Evaluate COVID-19 Vaccines & Side Effects

Impfungen, Booster und Genesung: Immunität gegen Corona stabil – mit Einschränkungen